Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A fusion protein under development for the treatment of cancer.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word aflibercept.

Examples

  • Eylea, chemically known as aflibercept to treat wet age-related macular degeneration, would compete with Lucentis from Basel, Switzerland-based

    unknown title 2011

  • The Paris-based drug maker said it will refocus its resources on more promising late-stage products, including the pediatric vaccine Hexaxim and the cancer treatment aflibercept.

    Sanofi to Winnow Drugs From Pipeline 2009

  • The Tarrytown, N.Y., drug company's aflibercept treatment, being developed in partnership with large-cap Sanofi-Aventis, failed in a Phase II study in advanced ovarian cancer.

    Tween Brands, Petroleum Development 2008

  • InPlay: Regeneron announces review of biologics license application for EYLEA aflibercept injection extended by three months by FDA

    unknown title 2011

  • Throughout 2011, further newsflow from R&D is expected with Phase III studies expected to be completed/reported for five compounds currently in development lixisenatide, teriflunomide, aflibercept, ombrabulin, and semuloparin.

    unknown title 2011

  • Bayer HealthCare will market EYLEA™ aflibercept injection outside the United States, where the companies will share equally the profits from any future sales of EYLEA.

    unknown title 2011

  • EYLEA (aflibercept injection) for intravitreal use, also known as VEGF Trap-Eye, is a fully human fusion protein, consisting of portions of VEGF receptors 1 and 2, that binds all forms of VEGF-A along with the related Placental Growth Factor (PlGF).

    unknown title 2011

  • Regeneron shares jump after CEO touts drugs cancer data next year * Says aflibercept has best chance against colon cancer * Says drug may have less blood-clot risk than Avastin * Shares up

    WN.com - Articles related to Biologics Boondoggle 2010

  • Regeneron also has two other phase 3 compounds: cancer drug aflibercept and its already-approved Arcalyst, which is being tested as a treatment for gout.

    Painful Clinical Hold? Not Really. (ABT, JNJ, PFE, REGN, SNY) 2010

  • Regeneron also has two other phase 3 compounds: cancer drug aflibercept and its already-approved Arcalyst, which is being tested as a treatment for gout.

    Painful Clinical Hold? Not Really. (ABT, JNJ, PFE, REGN, SNY) 2010

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.